Insider Transactions in Q2 2021 at Opiant Pharmaceuticals, Inc. (OPNT)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2021
|
Craig A Collard Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+33.33%
|
-
|
|
Jun 15
2021
|
Masuoka K. Lorianne Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+50.0%
|
-
|
|
Jun 15
2021
|
Gabrielle Alison Silver Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+9.6%
|
-
|
|
Jun 15
2021
|
Ann L. Mac Dougall Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+7.94%
|
-
|
|
Jun 15
2021
|
Richard J Daly Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+25.64%
|
-
|
|
Jun 15
2021
|
Thomas T. Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+22.22%
|
-
|
|
May 13
2021
|
Ann L. Mac Dougall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
341
+1.58%
|
$3,410
$10.0 P/Share
|
|
May 13
2021
|
Gabrielle Alison Silver Director |
BUY
Exercise of conversion of derivative security
|
Direct |
365
+2.12%
|
$3,650
$10.0 P/Share
|